IES-ACap: Influence of Atrial Pulse Width in the Behaviour of ACap™ Confirm Algorithm.
Completed
- Conditions
- Sinus BradycardiaSinus Node DiseaseAtrio-ventricular Block
- Registration Number
- NCT00832260
- Lead Sponsor
- Abbott Medical Devices
- Brief Summary
The purpose of this observational study is to collect data regarding the population of patients with a pacemaker implanted.
- Detailed Description
The purpose of this observational study is to collect data regarding the population of patients whit a Zephyr™ pacemaker implanted, models 5826 and 5820, and active or passive fixation leads , when the Algorithms Acap Confirm, which automatically regulates the Atrial Pulse Width, is enabled.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
- Patient has an indication for implantation of a dual-chamber pacemaker;
- Patient is older than 18 years of age
- Patient has signed the study specific Informed consent document.
- Primo implant.
Exclusion Criteria
- Patient is pregnant or nursing
- Patient is less than 18 years of age
- Patient is in New York Heart Association (NYHA) class III and IV.
- Patient has a pacemaker replacement;
- Patient is unable to attend the follow-up visits;
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of Patients in Whom ACap™ Confirm Algorithm is Programmed Safely to ON During the First 12 Months. 12 months
- Secondary Outcome Measures
Name Time Method Percentage of Patients in Whom ACap™ Confirm Algorithm is Recommended at a Pulse Width of 0.4 Milliseconds (ms) During All Follow-ups (Implant, Staples Removal, 3, 6, 9 and 12 Months). 12 months